CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

8 hedge funds and large institutions have $13.7M invested in Celyad Oncology SA American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-4
Holders Change %
-33.33%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Victory Capital Management
1
Victory Capital Management
Texas
$11.7M +$457K +25,189 +4%
Millennium Management
2
Millennium Management
New York
$1.65M +$675K +37,171 +70%
Morgan Stanley
3
Morgan Stanley
New York
$140K +$67.5K +3,707 +93%
Wells Fargo
4
Wells Fargo
California
$113K +$3.25K +179 +3%
UBS Group
5
UBS Group
Switzerland
$24K -$9.18K -503 -28%
Bank of Montreal
6
Bank of Montreal
Ontario, Canada
$2K
Zurich Cantonal Bank
7
Zurich Cantonal Bank
Switzerland
$2K
TRCT
8
Tower Research Capital (TRC)
New York
$2K +$2K +107 New
SLG
9
Stanley-Laman Group
Pennsylvania
-$1.05M -39,750 Closed
Deutsche Bank
10
Deutsche Bank
Germany
-$155K -5,834 Closed
AG
11
Advisor Group
Arizona
-$21K -800 Closed
PA
12
Parallel Advisors
California
-$7K -281 Closed
US Bancorp
13
US Bancorp
Minnesota
-$2K -79 Closed